The DOI matches its Crossref record; 454 of the 464 references it cites were found in a registry or an index; 60 of the 171 sources its claims cite were checked for support.
GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
Open accessAbstract
Glycans are one of the four fundamental macromolecular components of living matter, and they are highly regulated in the cell. Their functions are metabolic, structural and modulatory. In particular, ER resident N-glycans participate with the Glc3Man9GlcNAc2 highly conserved sequence, in protein folding process, where the physiological balance between glycosylation/deglycosylation on the innermost glucose residue takes place, according GANAB/UGGT concentration ratio. However, under abnormal conditions, the cell adapts to the glucose availability by adopting an aerobic or anaerobic regimen of glycolysis, or to external stimuli through internal or external recognition patterns, so it responds to pathogenic noxa with unfolded protein response (UPR). UPR can affect Multiple Sclerosis (MS) and several neurological and metabolic diseases via the BiP stress sensor, resulting in ATF6, PERK and IRE1 activation. Furthermore, the abnormal GANAB expression has been observed in MS, systemic lupus erythematous, male germinal epithelium and predisposed highly replicating cells of the kidney tubules and bile ducts. The latter is the case of Polycystic Liver Disease (PCLD) and Polycystic Kidney Disease (PCKD), where genetically induced GANAB loss affects polycystin-1 (PC1) and polycystin-2 (PC2), resulting in altered protein quality control and cyst formation phenomenon. Our topics resume the role of glycans in cell physiology, highlighting the N-glycans one, as a substrate of GANAB, which is an emerging key molecule in MS and other human pathologies.
Overview
CoChat Summary
TL;DR
This review synthesizes glycobiology and the roles of GANAB/glucosidase II in ER N-glycan processing, unfolded protein response, and human disease. It highlights GANAB dysregulation in multiple sclerosis, polycystic liver/kidney disease, systemic lupus erythematosus, and other conditions, proposing GANAB as a biomarker and therapeutic target.
Key findings
- GANAB encodes the catalytic α-subunit of glucosidase II (GII), a heterodimer with the β-subunit PRKCSH; the human α-subunit is 944 amino acids with a 912-amino-acid catalytic domain (~103 kDa), and the β-subunit is 528 amino acids (~58 kDa). GII trims glucose residues from the Glc3Man9GlcNAc2 N-glycan in ER glycoprotein quality control.
- GANAB expression is highest in liver, followed by epididymis ductal cells, with kidney among top expression sites; abnormal GANAB expression is reported in multiple sclerosis (MS), systemic lupus erythematosus, male germinal epithelium, and highly replicating kidney tubule/bile duct cells.
- In MS, GANAB was upregulated in untreated relapsing-remitting MS patients compared with IFN-treated and other disease-modifying-therapy-treated patients, downregulated in treatment responders versus nonresponders, and higher in healthy controls than untreated RRMS patients; it correlated with lesion load, disease duration, and the Rio score.
- In autosomal dominant polycystic liver and kidney disease, GANAB mutations cause defective glucose trimming of N-glycan moieties and increased apparent molecular mass of polycystin-1; ADPLD genes explain only 25–30% of the genetic spectrum, and GANAB loss affects polycystin-1/polycystin-2 and cyst formation.
Methods
- Narrative review of glycobiology, GANAB/glucosidase II structure and function, unfolded protein response, and disease literature; no systematic review protocol or meta-analysis is described.
- Evidence is drawn from cited experimental, genetic, clinical, and animal studies; no primary data collection or new patient cohort is reported.
- Main analysis is a qualitative synthesis linking GANAB/N-glycan biology to human physiology and pathologies.
Limitations
- The authors state that glycomics knowledge is scattered and lacks a holistic/systematic view; for MS, no other published articles on GANAB were available to them; except for MS and polycystic kidney/liver disease, the relation between human pathology and α-glycosidases is only conceivable and not concretely demonstrated; more comprehensive studies are warranted.
- Evident from the text: as a narrative review, it lacks systematic search/selection criteria and formal quality assessment, so selection bias and reliance on heterogeneous evidence are possible.
- Evident from the text: conclusions often rest on animal or cell models and correlative human findings, so causality is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
54 Valid · 22 Not valid · 70 Not checked · 43 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition, Glucosidase II is involved in human polycystic disease [8,9,10] and finally in the demyelinating ones of the central nervous system (CNS), according to the latest evidence [11].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [8] Drenth, 2003, Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease, Nat. Genet. source
- Not checked — no full text of the sourcecites [9] Li, 2003, Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease, Am. J. Hum. Genet. source
- Supportedcites [10] Porath, 2016, Genkyst Study Group; HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease; Harris, P.C. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease, Am. J. Hum. Genet. source
The Results identify GANAB as encoding the catalytic α subunit of glucosidase II and link mutations in the enzyme’s β subunit to polycystic liver disease. The paper’s title and figure legend also link GANAB mutations to affected people with kidney and liver cysts, supporting the broad claim that glucosidase II is involved in human polycystic disease. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“We know why partially glycosylated proteins have a shorter lifetime than fully glycosylated ones, due to the binding of galactose with hepatic asialoglycoprotein receptors expressed on hepatocytes, which promotes hepatic clearance of the partially glycosylated proteins [217].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 6. Glycodrugs
What the sources say
- Supportedcites [217] Zhang, 2016, Glycan analysis of therapeutic glycoproteins, MAbs source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Many studies have found evidence of sustained and high-level activation of all three branches of the UPR (PERK, ATF6, IRE1α) in different tumors, including glioblastoma, MM, carcinomas of the breasts, stomach, esophagus, and liver [304,406,407,408,409].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.3. Cancer
What the sources say
- Not checked — no full text of the sourcecites [304] Shuda, 2003, Activation of the atf6, xbp1 and grp78 genes in human hepatocellular carcinoma: A possible involvement of the er stress pathway in hepatocarcinogenesis, J. Hepatol. source
- Partly supportedcites [406] Carrasco, 2007, The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis, Cancer Cell sourceExperimental — accuracy not yet measured
The Introduction reports elevated XBP-1 expression in multiple myeloma, breast tumors, and hepatocellular carcinomas, while the Discussion links sustained XBP-1s overexpression to myeloma development. The paper does not establish sustained, high-level activation of all three UPR branches in those tumors, or address that claim for glioblastoma, stomach, or esophageal carcinomas. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [407] Fernandez, 2000, Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions, Breast Cancer Res. Treat. source
- Not checked — no full text of the sourcecites [408] Song, 2001, Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-ε/ERK/AP-1 signaling cascade, Cancer Res.
- Not checked — no full text of the sourcecites [409] Chen, 2002, Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans, Carcinogenesis source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.5. ADPLD and ADPKD
What the sources say
- Not checked — no full text of the sourcecites [426] Waanders, 2006, Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease, Hum. Mutat. source
- Partly supportedcites [427] Hopp, 2012, Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links lower mature PC-1 dosage to more severe cystic disease, supporting the dose-dependent part of the claim. But the paper studies a Pkd1 variant, not mutations in Prksch or Sec63; its Figure 8 passage says the mutant PC-1 that reached urinary vesicles trafficked appropriately. It therefore does not establish the claimed effects of those two genes on PC-1 expression, stability, or trafficking. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The level of functional PC1 at the cilium is thought to be central to the development of both hepatic and kidney cysts [428].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.5. ADPLD and ADPKD
What the sources say
- Supportedcites [428] Kim, 2014, Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism, Nat. Commun. source
The Discussion calls PC1 the central determinant of cyst formation in polycystic kidney and liver diseases and identifies it as the rate-limiting factor for ciliary trafficking of the polycystin complex. The paper also states that loss of polycystin function in cilia is implicated in cyst formation. Together, these support the citing sentence’s hedged claim. (LLM, conf=0.87)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
85 more claims · 26 with their cited sources checked
Create a free account to see all 189 claims and to verify the 17 references still open.
- It may state two separate claims as one. 56
- Probably not a substantial claim. 68
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 7. Protein Folding and Folding Quality Control Machinery > The UPR
“the α-GluI operates a first cleavage by removing a glucose residue from the conserved Glc2Man9GlcNAc2 N-linked glycan attached to nascent glycoprotein, and the resulting Glc1Man9GlcNAc2 glycan”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 7. Protein Folding and Folding Quality Control Machinery > The UPR
“ER-resident GluI and GluII sequentially trim the three terminal glucose moieties on N-linked Glc3Man9GlcNAc2 glycan coupled en bloc to nascent glycoproteins by oligosaccharyltransferase (OST)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 10. Conclusions
“the catalytic one is responsible for innermost glucose trimming on the Glc3Man9GlcNAc2 precursor signal. This reaction allows the nascent peptide to enter the CNX/CRT cycle for maturation.”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.5. ADPLD and ADPKD
“The subsequent removal of the innermost glucose by GII allows for the exit of the protein, if properly folded. In this case, it can proceed along the secretory pathway.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 6. Glycodrugs > 6.3. Viral Infections and Glycodrugs
“The FDA-approved drug is called Relenza.”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 4. Recognition Patterns of Glycans
“the specific neuraminidase inhibitor zanamivir (Relenza) [103,104] projected onto the previously known sialidase inhibitor Neu5Ac2en [105]”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 8. The GANAB > 8.1. The Structure and Localization Glucosidase II
“the inner one exposes the Glc residue to the catalytic site on the GIIβ [369].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 8. The GANAB > 8.1. The Structure and Localization Glucosidase II
“α-Glucosidase II (GluII or GII) consists of a 110 kDA catalytic α-subunit (GIIα) and 60 kDA regulatory β-subunit (GIIβ).”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“stress resulting in the induction of UPR, chaperones, and apoptotic markers [400,401].”
Cited work 10.1016/j.nbd.2008.02.009 · retracted 2020-12-25 · notice 10.1016/j.nbd.2020.105232 · this paper published 2022-07-01
Citations
Cites
1 retracted
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350 · cited 5×
“stress resulting in the induction of UPR, chaperones, and apoptotic markers [400,401].”
InfluentialRetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 2×
“Another adopted strategy for carbohydrate-based cancer drug discovery refers to increasing the number of glucose transporters (GLUTs) and lectins on the membrane surface as well as increasing the uptake of glucose by cancer cells at a rate higher than that of normal cells, referred to as the Warburg effect [17].”
BackgroundDown-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E., Bock, C.-T., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,675
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“In immunological terms, it is also known that immune cells can elicit the innate immune response by detecting damage-associated molecular patterns (DAMPs) or pathogenassociated molecular patterns (PAMPs) using Pattern Recognition Receptors (PRRs) [107], such as Toll-like receptors (TLRs) [108,109], NOD-like receptors…”
BackgroundControl of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., De Smedt, H., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,120
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“In fact, the pathologic hallmark of many neurodegenerative diseases is already known as the accumulation of misfolded proteins in the form of aggregates within affected neurons [396].”
BackgroundProtein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310 · cited 2×
“Sci. 2022, 23, 7373 20 of 49 (CHOP), a transcription factor whose expression is stimulated by ATF4; thus, the PERKeIF2α pathway is regulated via a tight autofeedback loop [328].”
BackgroundRegulation of cell death: the calcium–apoptosis link
Orrenius, S., Zhivotovsky, B., & Nicotera, P. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1150 · Cited by 3,012 · cited 1×
“Stressinduced apoptosis can occur through both mitochondrial-dependent and independent pathways [345].”
Background
Research works printed but not linked: 8
- Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2022, February 28). Sialic Acids, Essentials of Glycobiology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK1920/.
- Taylor, M.E., and Drickamer, K. (2006). Introduction to Glycobiology, Oxford University Press. [2nd ed.].
- Varki, A., Cummings, R., Esko, J., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2022, February 28). Essentials of Glycobiology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK20705/.
- Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2009). N-Glycans. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press.
- Voet, D., Voet, J.G., and Pratt, C.W. (1999). Fundamentals of Biochemistry, John Wiley & Sons, Inc.
- Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2009). O-GalNAc Glycans. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press. [2nd ed.]. Chapter 9.
- Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2022, February 28). The O-GlcNAc Modification, Essentials of Glycobiology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK453063/.
- Janeway, C.A., Travers, P., Walport, M., Walport, M., and Shlomchik, M.J. (2022, February 28). Antigen receptor structure and signaling pathways, Immunobiology: The Immune System in Health and Disease, Available online: https://www.ncbi.nlm.nih.gov/books/NBK27130/.
Cited by
Multi-scale signaling and tumor evolution in high-grade gliomas
Liu, J., Cao, S., Imbach, K. J., Gritsenko, M. A., Lih, T. M., Kyle, J. E., Yaron-Barir, T. M., Binder, Z. A., Li, Y., Strunilin, I., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.06.004 · Cited by 80
Ramaprabha, K., Kumar, S. V., Saravanan, P., Rajeshkannan, R., Rajasimman, M., Kamyab, H., & Vasseghian, Y. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117521 · Cited by 64
Xue, X., Wu, X., Liu, L., Liu, L., & Zhu, F. (2023) · Viruses · doi:10.3390/v15061298 · Cited by 15
Withana, M., & Castorina, A. (2023) · Cells · doi:10.3390/cells12222633 · Cited by 12
“Post-mortem analyses of human CNS tissues have demonstrated the presence of activated IRE1 α and UPR in patients with Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS) [47].”
BackgroundSoloveva, N. A., Novikova, S. E., Farafonova, T. E., Tikhonova, O. V., & Zgoda, V. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031016 · Cited by 10
Metadata
- Authors
- De Masi, R., & Orlando, S.
- Affiliations
- Complex Operative Unit of Neurology, “F. Ferrari” Hospital, Casarano, 73042 Lecce, Italy
- Laboratory of Neuroproteomics, Multiple Sclerosis Centre, “F. Ferrari” Hospital, Casarano, 73042 Lecce, Italy
- Corresponding author
- Orlando, Stefania
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-07-01
- Volume
- 23
- Issue
- 13
- Pages
- 7373
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9266668
- OpenAlex
- W4283802200
- Cited by
- 20
- References
- 464
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 3 · 2023: 5
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GANAB, N-glycans, N-acetyl-beta-D-glucosaminidase, polycystic kidney disease, polycystic liver disease, multiple sclerosis, unfolded protein response, polycystin-1, polycystin-2, protein folding, glycosylation, ATF6, PERK, IRE1, BiP, systemic lupus erythematosus, cyst formation
- MeSH terms
- Glucose, Humans, Male, Multiple Sclerosis, Polysaccharides, TRPP Cation Channels, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. https://app.cochat.ai/papers/10.3390/ijms23137373
- The paper
- De Masi, R., & Orlando, S. (2022). GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23137373
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.